Loss of heterozygosity at the ATBF1-A locus located in the 16q22 minimal region in breast cancer

por Kai, Kazuharu, Zhang, Zhenhuan, Yamashita, Hiroko, Yamamoto, Yutaka, Miura, Yutaka, Iwase, Hirotaka
Publicado 2008

The Impact of Immunofunctional Phenotyping on the Malfunction of the Cancer Immunity Cycle in Breast Cancer

por Takeshita, Takashi, Torigoe, Toshihiko, Yan, Li, Huang, Jing Li, Yamashita, Hiroko, Takabe, Kazuaki
Publicado 2020

Genetic heterogeneity during breast cancer progression in young patients

por Hagio, Kanako, Hatanaka, Kanako C., Amano, Toraji, Matsuno, Yoshihiro, Hatanaka, Yutaka, Yamashita, Hiroko
Publicado 2021

Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer

por Yamashita, Hiroko, Nishio, Mariko, Toyama, Tatsuya, Sugiura, Hiroshi, Zhang, Zhenhuan, Kobayashi, Shunzo, Iwase, Hirotaka
Publicado 2004

Reproductive history and breast cancer risk

por Kobayashi, Shunzo, Sugiura, Hiroshi, Ando, Yoshiaki, Shiraki, Norio, Yanagi, Takeshi, Yamashita, Hiroko, Toyama, Tatsuya
Publicado 2012

Myoepithelial Carcinoma of the Breast Treated with Surgery and Chemotherapy

por Endo, Yumi, Sugiura, Hiroshi, Yamashita, Hiroko, Takahashi, Satoru, Yoshimoto, Nobuyasu, Iwasa, Mai, Asano, Tomoko, Toyama, Tatsuya
Publicado 2013

A randomized controlled study evaluating safety and efficacy of leuprorelin acetate every-3-months depot for 2 versus 3 or more years with tamoxifen for 5 years as adjuvant treatme...

por Shiba, Eiichi, Yamashita, Hiroko, Kurebayashi, Junichi, Noguchi, Shinzaburo, Iwase, Hirotaka, Ohashi, Yasuo, Sasai, Kiyofumi, Fujimoto, Tsukasa
Publicado 2015

Collaborative care intervention for the perceived care needs of women with breast cancer undergoing adjuvant therapy after surgery: a feasibility study

por Momino, Kanae, Mitsunori, Miyashita, Yamashita, Hiroko, Toyama, Tatsuya, Sugiura, Hiroshi, Yoshimoto, Nobuyasu, Hirai, Kei, Akechi, Tatsuo
Publicado 2017

Comparison of quality of life between 2-year and 3-or-more-year administration of leuprorelin acetate every-3-months depot in combination with tamoxifen as adjuvant endocrine treat...

por Ohashi, Yasuo, Shiba, Eiichi, Yamashita, Hiroko, Kurebayashi, Junichi, Noguchi, Shinzaburo, Iwase, Hirotaka, Yoshida, Michihiro, Fujimoto, Tsukasa
Publicado 2017

Statistical analysis of the usefulness of follicle-sinus complexes as a novel diagnostic material for canine rabies

por SHIWA, Nozomi, YAMASHITA, Hiroko, TOMIOKA, Koki, KIMITSUKI, Kazunori, MANALO, Daria Llenaresas, INOUE, Satoshi, PARK, Chun-Ho
Publicado 2018

p53 protein accumulation predicts resistance to endocrine therapy and decreased post-relapse survival in metastatic breast cancer

por Yamashita, Hiroko, Toyama, Tatsuya, Nishio, Mariko, Ando, Yoshiaki, Hamaguchi, Maho, Zhang, Zhenhuan, Kobayashi, Shunzo, Fujii, Yoshitaka, Iwase, Hirotaka
Publicado 2006

Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers

por Toyama, Tatsuya, Yamashita, Hiroko, Kondo, Naoto, Okuda, Katsuhiro, Takahashi, Satoru, Sasaki, Hidefumi, Sugiura, Hiroshi, Iwase, Hirotaka, Fujii, Yoshitaka
Publicado 2008

Quantitative determination, by real-time reverse transcription polymerase chain reaction, of aromatase mRNA in invasive ductal carcinoma of the breast

por Zhang, Zhenhuan, Yamashita, Hiroko, Toyama, Tatsuya, Omoto, Yoko, Sugiura, Hiroshi, Hara, Yasuo, Wu, Xueqing, Kobayashi, Shunzo, Iwase, Hirotaka
Publicado 2003

Estrogen Receptor, c‐erbB‐2 and nm23/NDP Kinase Expression in the Intraductal and Invasive Components of Human Breast Cancers

por Kobayashi, Shunzo, Iwase, Hirotaka, Itoh, Yukashi, Fukuoka, Hideki, Yamashita, Hiroko, Kuzushima, Tatsuya, Iwata, Hiroji, Masaoka, Akira, Kimura, Narimichi
Publicado 1992

p53 accumulation is a strong predictor of recurrence in estrogen receptor-positive breast cancer patients treated with aromatase inhibitors

por Yamamoto, Mitsugu, Hosoda, Mitsuchika, Nakano, Kiichiroh, Jia, Shusheng, Hatanaka, Kanako C, Takakuwa, Emi, Hatanaka, Yutaka, Matsuno, Yoshihiro, Yamashita, Hiroko
Publicado 2014

Breast cancer detected as an incidental finding on (99m)Tc-MIBI scintigraphy

por Homma, Toshihiro, Manabe, Osamu, Ichinokawa, Kazuomi, Yamashita, Hiroko, Oyama-Manabe, Noriko, Kato, Fumi, Hirata, Kenji, Kroenke, Markus, Tamaki, Nagara
Publicado 2017

PIK3CA mutation, reduced AKT serine 473 phosphorylation, and increased ERα serine 167 phosphorylation are positive prognostic indicators in postmenopausal estrogen receptor-positiv...

por Ishida, Naoko, Baba, Motoi, Hatanaka, Yutaka, Hagio, Kanako, Okada, Hiromi, Hatanaka, Kanako C., Togashi, Kenichi, Matsuno, Yoshihiro, Yamashita, Hiroko
Publicado 2018

Phosphorylation of estrogen receptor α serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer

por Yamashita, Hiroko, Nishio, Mariko, Kobayashi, Shunzo, Ando, Yoshiaki, Sugiura, Hiroshi, Zhang, Zhenhuan, Hamaguchi, Maho, Mita, Keiko, Fujii, Yoshitaka, Iwase, Hirotaka
Publicado 2005

Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients

por Toyama, Tatsuya, Zhang, Zhenhuan, Nishio, Mariko, Hamaguchi, Maho, Kondo, Naoto, Iwase, Hirotaka, Iwata, Hiroji, Takahashi, Satoru, Yamashita, Hiroko, Fujii, Yoshitaka
Publicado 2007

Immunohistochemical determination of the miR-1290 target arylamine N-acetyltransferase 1 (NAT1) as a prognostic biomarker in breast cancer

por Endo, Yumi, Yamashita, Hiroko, Takahashi, Satoru, Sato, Shinya, Yoshimoto, Nobuyasu, Asano, Tomoko, Hato, Yukari, Dong, Yu, Fujii, Yoshitaka, Toyama, Tatsuya
Publicado 2014